Paroxysmal Atrial Fibrillation in the Course of Acute Pulmonary Embolism: Clinical Significance and Impact on Prognosis
Table 2
Comparison of the admission clinical parameters, Geneva risk score results, and sPESI score values in patients with sinus rhythm (SR), paroxysmal atrial fibrillation (paroxysmal AF), and permanent atrial fibrillation (permanent AF).
SR (), Me (Q1–Q3) or %
Paroxysmal AF (), Me (Q1–Q3) or %
Permanent AF (), Me (Q1–Q3) or %
value
PE symptoms
Syncope
19.0%
26.7%
10%
0.25
Chest pain
30.0%
36.7%
30%
0.75
Dyspnea
86.6%
96.7%
79.3%
0.14
Hemoptysis
2.0%
0
6.3%
0.2
Cough
8.3%
6.7%
16.7%
0.28
PE associated with DVT
49.5%
32.3%
28.1%
0.02
Risk factors
Immobilization
19.1%
19.4%
34.4%
0.13
Malignancy
17.8%
9.7%
18.8%
0.5
Pregnancy/delivery
3.3%
0
0
0.34
Recurrent PE
6.6%
0
3.1%
0.26
The revised Geneva risk score: clinical probability
0.04
Low
17.3%
16.1%
12.5%
Intermediate
76.1%
64.5%
68.8%
High
6.6%
19.4%
18.8%
sPESI score ≥ 1
56.2%
86.2%
82.6%
<0.001
Hemodynamic profile on admission
Heart rate, beats per minute
89.5 (78–103)
99 (78–124)
101 (81–122)
0.01
Tachycardia (>100 beats/minute)
32.0%
54.8%
50%
0.08
Systolic blood pressure, mmHg
130 (115–145)
125 (106–145)
126 (109–142)
0.6
Oxygen saturation, %
95 (92–97)
95 (90–97)
95 (90–96)
0.17
Me (Q1–Q3) or %: data presented as a median and interquartile range or a percent of the group. value . DVT: deep vein thrombosis; PE: pulmonary embolism.
